From October 28, 2023 to January 26, 2024, the company has repurchased 1,598,724 shares, representing 0.12% for $124.16 million. With this, the company has completed the repurchase of 92,465,168 shares, representing 6.87% for $9,082.87 million under the buyback announced on June 23, 2017.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
79.74 USD | +0.62% | +0.33% | -3.20% |
Apr. 26 | Medtronic Receives FDA Approval for Inceptiv Spinal Cord Stimulator to Treat Chronic Pain | MT |
Apr. 26 | Medtronic Gets FDA OK for Inceptiv Closed-Loop Spinal Cord Stimulator | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.20% | 106B | |
-2.31% | 187B | |
-5.04% | 66.9B | |
+0.20% | 49.45B | |
+17.29% | 48B | |
+4.06% | 40.84B | |
+2.07% | 26.48B | |
+2.36% | 26.25B | |
+12.96% | 24.62B | |
-1.93% | 24.52B |
- Stock Market
- Equities
- MDT Stock
- News Medtronic plc
- Tranche Update on Medtronic plc's Equity Buyback Plan announced on June 23, 2017.